- Home
- Life Sciences
- Pharmaceutical
- Drug and Medication
- Drug and Medication Analysis & Statistics, May 2013 (p40)
Talk to Robyn
(866) 682 9815
Search inside this page
Top countries
- World (1 023)
- United States (670)
- China (310)
- Japan (287)
- India (209)
-
- Australia (93)
- Europe (180)
- Sweden (53)
- South Korea (77)
- Germany (136)
- Greece (122)
- France (130)
- Canada (159)
- Venezuela (67)
- Kazakhstan (63)
- Italy (121)
- Poland (139)
- United Kingdom (137)
- Chile (71)
- Azerbaijan (17)
Publication dates
Publishers
- Global Data (481)
- Bioseeker (183)
- Global Research & Data Services (382)
- Global Markets Direct (753)
- Business Monitor International (3 619)
-
- Euromonitor International (431)
- Asia Market Information & Development Company (93)
- Infiniti Research Limited (47)
- Barnes Reports (8)
- GBI Research (36)
- Visiongain (59)
- MarketLine (47)
- Canadean Ltd (16)
- Currentpartnering (9)
- Espicom Business Intelligence (94)
- Greystone Research Associates (10)
- ICD Research (53)
- Ibisworld (11)
- La Merie Publishing (34)
- PMR Ltd. (6)
- Pacific Bridge Medical (3)
- RNCOS (10)
- Research In China (16)
- Transparency Market Research (9)
- TriMark Publications (4)
- World Market Intelligence Ltd (15)
- Chinascope Financial (25)
- Datamonitor (222)
- Life Science Analytics (LSA) (80)
- Frost & Sullivan (64)
- Global Industry Analyst (40)
- BCC Research (35)
- DrugPatentWatch - ThinkBiotech LLC (27)
- VacZine Analytics Group Of Assay Advantage Ltd (26)
- Kalorama Information (25)
- SCRIP Insights (24)
- Business Review (13)
- Aruvian's R'search (12)
- Koncept Analytics (12)
- BioPharm Reports (10)
- Daedal Research (10)
- Beijing Zeefer Consulting Ltd (9)
- Databank - Cerved Group (9)
- Venture Planning Group (9)
- CHI Insight Pharma Reports (8)
- Renub Research (8)
- CCM International Limited (6)
- Cygnus Business Consulting and Research (5)
- Firstword Pharma (5)
- Freedonia (5)
- Huidian Research (5)
- Ken Research Private (5)
- MarketsandMarkets (5)
- Lucintel (4)
- SeeNews - Research & Profiles (4)
- Urch Publishing (4)
- IData Research, Inc. (4)
- Emerging Markets Direct Media Holdings (3)
- Mintel (3)
- Netscribes (India) Pvt. Ltd. (3)
- Plimsoll Publishing Ltd UK (3)
- Access China Management Consulting Ltd. (2)
- Beremans Ltd (2)
- IPEXL (2)
- International Market Analysis Research and Consult (2)
- Arrowhead (1)
- Beijing HuaJing Ltd (1)
- Beijing Shennong Kexin Agribusiness Consulting Co. (1)
- Berlingske Research (1)
- BusinesStat (1)
- Dolcera Corporation (1)
- IndexBox Marketing (1)
- Key Note Publications Ltd (1)
- Leatherhead Food Research (1)
- Marketest (1)
- Reports from China (1)
- Smithers Rapra Technology Ltd (1)
- Strategic Defence Intelligence (SDI) (1)
- Xerfi (1)
- Zzz- Tiarta L.L.C (1)
All regions
-
- Algeria (22)
- Botswana (1)
- Burkina Faso (6)
- Cameroon (9)
- Central African Republic (6)
- Congo, Democratic Republic Of (1)
- Egypt (73)
- Eritrea (3)
- Ethiopia (10)
- Gabon (6)
- Gambia (1)
- Ghana (17)
- Guinea (6)
- Kenya (25)
- Libyan Arab Jamahiriya (1)
- Madagascar (10)
- Malawi (10)
- Mali (6)
- Mauritius (10)
- Morocco (29)
- Mozambique (8)
- Namibia (10)
- Niger (10)
- Nigeria (30)
- Senegal (14)
- South Africa (79)
- Sudan (5)
- Tanzania (4)
- Tunisia (14)
- Uganda (12)
- Zambia (9)
- Zimbabwe (19)
-
- Afghanistan (4)
- Armenia (15)
- Azerbaijan (17)
- Bahrain (17)
- Bangladesh (27)
- Bhutan (2)
- Cambodia (5)
- China (310)
- Georgia (18)
- India (209)
- Indonesia (43)
- Iran (36)
- Israel (134)
- Japan (287)
- Jordan (23)
- Kazakhstan (63)
- Kuwait (21)
- Kyrgyz Republic (kyrgyzstan) (4)
- Lebanon (49)
- Malaysia (44)
- Maldives (2)
- Mongolia (13)
- Nepal (10)
- Oman (59)
- Pakistan (31)
- Philippines (50)
- Qatar (18)
- Saudi Arabia (27)
- Singapore (47)
- South Korea (77)
- Sri Lanka (15)
- Syrian Arab Republic (10)
- Taiwan (38)
- Thailand (51)
- Turkey (20)
- United Arab Emirates (31)
- Uzbekistan (11)
- Vietnam (33)
- Yemen (11)
-
- Albania (5)
- Austria (21)
- Belarus (24)
- Belgium (45)
- Bosnia and Herzegovina (14)
- Bulgaria (69)
- Croatia (61)
- Cyprus (12)
- Czech Republic (110)
- Denmark (37)
- Estonia (55)
- Finland (37)
- France (130)
- Germany (136)
- Greece (122)
- Hungary (104)
- Iceland (11)
- Ireland (45)
- Italy (121)
- Latvia (67)
- Liechtenstein (1)
- Lithuania (27)
- Luxembourg (10)
- Macedonia (17)
- Malta (11)
- Moldova, Republic Of (55)
- Netherlands (53)
- Norway (24)
- Poland (139)
- Portugal (44)
- Romania (71)
- Russian Federation (172)
- Serbia and Montenegro (64)
- Slovakia (slovak Republic) (111)
- Slovenia (64)
- Spain (117)
- Sweden (53)
- Switzerland (51)
- Ukraine (70)
- United Kingdom (137)
-
- Australia (93)
- Austria (21)
- Belgium (45)
- Canada (159)
- Chile (71)
- Czech Republic (110)
- Denmark (37)
- Estonia (55)
- Finland (37)
- France (130)
- Germany (136)
- Greece (122)
- Hungary (104)
- Iceland (11)
- Ireland (45)
- Israel (134)
- Italy (121)
- Japan (287)
- Luxembourg (10)
- Mexico (105)
- Netherlands (53)
- New Zealand (33)
- Norway (24)
- Poland (139)
- Portugal (44)
- Slovenia (64)
- South Korea (77)
- Spain (117)
- Sweden (53)
- Switzerland (51)
- Turkey (20)
- United Kingdom (137)
- United States (670)
data types
Free Market Research Guides to Download
Drug and Medication Analysis & Statistics, May 2013 (p40)
You might be interested in: drug, vaccine, insulin, more »
» Purchase Premium Reports
1171-1210 of about 3 800 reports
Number Of Approvals Of Registration-drug_new Drug Certificate-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_production Of New Drugs That Go Through Relevant Reporting Procedures-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Export Amount-pharmaceuticals_chinese Patent Medicine-china-annual, In Usd (ten Thousands)
- $ 250
- Industry data
- May 2013
Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_imported Drug Re-registration-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_new Drug Certificate And Production-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Ex-factory Price Indices Of Industrial Products-manufacture Of Medicines-china-yoy Growth-annual, In Preceding Year = 100
- $ 250
- Industry data
- May 2013
Yearly, From 1986 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_drug Filing-china-state Bureau-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_certificates And Production Of New Drugs That Go Through Relevant Reporting Procedures-china-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Number Of Approvals Of Registration-drug_drug Supplementary-china-provincial Bureau-annual, In Unit (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2006 To 2010
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Export Volume-pharmaceuticals_chinese Patent Medicine-china-annual, In Tonne (units)
- $ 250
- Industry data
- May 2013
Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial
- Industries : Drug and Medication
Bahrain Pharmaceuticals and Healthcare Industry Update Quarter 4 2011
- $ 1 088
- Industry report
- September 2012
- by Business Monitor International
BMI View: Locking up doctors and arresting patients suspected of participating in protests will make Bahrain unattractive to local and foreign medical professionals, increase over-the-counter (OTC) spending ...
- Industries : Drug and Medication
- Countries : Bahrain
Thailand Pharmaceuticals and Healthcare Industry Update Quarter 4 2011
- $ 1 088
- Industry report
- September 2012
- by Business Monitor International
BMI View: Thailand pharmaceutical industry remains a longer-term attractive industry for investors with larger risk capacity. The attractiveness of the industry will continue to be backed by steady growth ...
- Industries : Drug and Medication
- Countries : Thailand
Apnea - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Apnea - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Apnea - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on ...
- Industries : Drug and Medication
- Countries : United States, World
Panacea Biotec Limited - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Panacea Biotec Limited - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Panacea Biotec Limited - Product Pipeline Review - 2012? provides data on the Panacea Biotec ...
- Industries : Drug and Medication
- Countries : World, Japan
Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2012? ...
- Industries : Drug and Medication
- Countries : India, World
Musculoskeletal Pain - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Musculoskeletal Pain - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Musculoskeletal Pain - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Drug and Medication
- Countries : United States, World
Dengue - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Dengue - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Dengue - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Drug and Medication
- Countries : World
Inviragen, Inc. - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Inviragen, Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Inviragen, Inc. - Product Pipeline Review - 2012? provides data on the Inviragen, Inc.'s research ...
- Industries : Drug and Medication
- Countries : World, Japan
Bone Sarcoma - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Bone Sarcoma - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Bone Sarcoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Drug and Medication
- Countries : World
Nosocomial Infections - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Nosocomial Infections - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Nosocomial Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Drug and Medication
- Countries : World
Opium (Opioid) Addiction - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Opium (Opioid) Addiction - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Opium (Opioid) Addiction - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. ...
- Industries : Drug and Medication
- Countries : World
Neutropenia - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Neutropenia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Neutropenia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Drug and Medication
- Countries : World
Other Dermatological Disorders - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Other Dermatological Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Other Dermatological Disorders - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic ...
- Industries : Drug and Medication
- Countries : World, United States
Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012
- $ 2 500
- Industry report
- September 2012
- by Global Markets Direct
Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012', provides an overview of the indication's ...
- Industries : Drug and Medication
- Countries : United States
Haemophilus Infections - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Haemophilus Infections - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Haemophilus Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. ...
- Industries : Drug and Medication
- Countries : Japan, World
Overactive Bladder - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Overactive Bladder - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Overactive Bladder - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...
- Industries : Drug and Medication
- Countries : United States, World
Mycobacterium Tuberculosis Infections - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Mycobacterium Tuberculosis Infections - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Mycobacterium Tuberculosis Infections - Pipeline Review, H2 2012', provides an overview of the indication's ...
- Industries : Drug and Medication
Pevion Biotech AG - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Pevion Biotech AG - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Pevion Biotech AG - Product Pipeline Review - 2012? provides data on the Pevion Biotech AG's ...
- Industries : Drug and Medication
- Countries : World
World Drug and Medication: Typhoid Fever - Pipeline Review, H2 2011
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Ependymoma - Pipeline Review, H2 2011 Global Industries Direct's, 'Ependymoma - Pipeline Review, H2 2011', provides an overview of the Ependymoma therapeutic pipeline. This report provides data on the ...
- Industries : Drug and Medication
- Countries : World, United States
Fatigue - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Fatigue - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Fatigue - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Drug and Medication
- Countries : World, Argentina
Drug and Medication in United States: GenPhar, Inc. ? Product Pipeline Review - H2 2011
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
- Product Pipeline Review - H2 2011? provides a detailed overview on the GenPhar, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest ...
- Industries : Drug and Medication
- Countries : World
Etubics Corporation - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Etubics Corporation - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Etubics Corporation - Product Pipeline Review - 2012? provides data on the Etubics Corporation's ...
- Industries : Drug and Medication
- Countries : World
FIT Biotech Oyj - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
FIT Biotech Oyj - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?FIT Biotech Oyj - Product Pipeline Review - 2012? provides data on the FIT Biotech Oyj's research ...
- Industries : Drug and Medication
- Countries : World, Finland
Spinal Cord Disorders - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Spinal Cord Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Spinal Cord Disorders - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Drug and Medication
- Countries : India
Drug and Medication Industry: Dr. Falk Pharma GmbH - Product Pipeline Review - Q4 2010
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Falk Pharma GmbH - Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with ...
- Industries : Drug and Medication
- Countries : World
Relapsed Multiple Myeloma - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Relapsed Multiple Myeloma - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Relapsed Multiple Myeloma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. ...
- Industries : Drug and Medication
- Countries : World
Diarrhea - Pipeline Review, H2 2012
- $ 2 000
- Industry report
- September 2012
- by Global Markets Direct
Diarrhea - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Diarrhea - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Drug and Medication
- Countries : Sweden, World
Crucell N.V. - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Crucell N.V. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Crucell N.V. - Product Pipeline Review - 2012? provides data on the Crucell N.V.'s research and development ...
- Industries : Drug and Medication
Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2012
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2012? provides data on ...
- Industries : Drug and Medication
- Countries : United States, World
Drug and Medication in Australia: Cephalon, Inc. ? Product Pipeline Review - H2 2011
- $ 1 500
- Industry report
- September 2012
- by Global Markets Direct
- Product Pipeline Review - H2 2011? provides a detailed overview on the Cephalon, Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest ...
- Industries : Drug and Medication
- Countries : World, Australia
» Download Public Reports
About 11 000 reports
Value Of Manufacturers' Shipments For Nondurable Goods Industries: Chemical Products: Pharmaceuticals And Medicines
- Industry data
- February 2013
Monthly, From 1992 To 2012
Source: U.S. Department of Commerce: Census Bureau
Brazil: Demographic Analysis, 2013
April 2013Company Report: Drug For Year 2013
April 2013Drug And Medication Industry Analysis
April 2013Vaccine Market In Tanzania
May 2013Drug Sector In Africa
April 2013» Read our Company Profiles
71 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandJohnson and Johnson
United StatesHealthcare Insurance
CanadaPfizer Inc.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
